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Co-morbid mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) has
become the signature disorder for returning combat veterans. The clinical heterogeneity
and overlapping symptomatology of mTBI and PTSD underscore the need to develop a
preclinical model that will enable the characterization of unique and overlapping features
and allow discrimination between both disorders. This study details the development and
implementation of a novel experimental paradigm for PTSD and combined PTSD-mTBI.
The PTSD paradigm involved exposure to a danger-related predator odor under repeated
restraint over a 21 day period and a physical trauma (inescapable footshock). We
administered this paradigm alone, or in combination with a previously established mTBI
model. We report outcomes of behavioral, pathological and biochemical profiles at an
acute timepoint. PTSD animals demonstrated recall of traumatic memories, anxiety and
an impaired social behavior. In both mTBI and combination groups there was a pattern of
disinhibitory like behavior. mTBI abrogated both contextual fear and impairments in social
behavior seen in PTSD animals. No major impairment in spatial memory was observed
in any group. Examination of neuroendocrine and neuroimmune responses in plasma
revealed a trend toward increase in corticosterone in PTSD and combination groups, and
an apparent increase in Th1 and Th17 proinflammatory cytokine(s) in the PTSD only and
mTBI only groups respectively. In the brain there were no gross neuropathological changes
in any groups. We observed that mTBI on a background of repeated trauma exposure
resulted in an augmentation of axonal injury and inflammatory markers, neurofilament L
and ICAM-1 respectively. Our observations thus far suggest that this novel stress-trauma-
related paradigm may be a useful model for investigating further the overlapping and
distinct spatio-temporal and behavioral/biochemical relationship between mTBI and PTSD
experienced by combat veterans.
Keywords: post-traumatic stress disorder, mild traumatic brain injury, mouse models, anxiety and social behavior,
cognitive function, plasma and brain biomarkers
INTRODUCTION
There is a growing awareness of the consequences of mild trau-
matic brain injury (mTBI) and post-traumatic stress disorder
(PTSD) in the veteran population of recent conflicts in Iraq and
Afghanistan. mTBI is a complex clinicopathological entity, caused
by external impact to the head or by a pressurized wave blast
injury, resulting in a rapid rotational acceleration/deceleration of
the brain in the closed skull of restrained occupants. Described as
the major signature injury of these recent conflicts, approximately
18% of returning veterans have been diagnosed as having mTBI
primarily due to exposures to combat related blast injuries from
improvised explosive devices (Hoge et al., 2008).
Although the nature of a mTBI is such that there is a lack of
overt brain damage such as hemorrhage or abnormalities visi-
ble from conventional computed tomography (CT) imaging scan,
patients can eventually develop a complex clinical profile involv-
ing neurological symptoms such as: chronic headaches, dizziness,
vertigo, memory-executive dysfunction, and loss of concen-
tration (Bogdanova and Verfaellie, 2012). Neuropsychological
symptoms can also arise due to the trauma surrounding the
injury and involve insomnia, depression, irritability, impulsive-
ness, anxiety, apathy and aggression, resembling a cluster of
PTSD like symptoms as clinically defined by the diagnostic
and statistical manual of mental disorders (5th Edn.; DSM-5;
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American Psychiatric Association, 2013; see also Vanderploeg
et al., 2012; Vasterling et al., 2012). Hoge et al. (2008) found
that 44% of Iraq war returnees who experienced a loss of con-
sciousness as a result of brain trauma also met the criteria for
PTSD 3–4 months after deployment, compared to 27% of those
reporting altered mental status, 16% with other injuries, and
9% with no injury. Combat related mTBI has also been demon-
strated to approximately double the risk for PTSD (Schneiderman
et al., 2008; Barnes et al., 2012; Bazarian et al., 2013). Over
300,000 service members (approximately one in five) to date
are estimated to experience symptoms of PTSD. PTSD is trig-
gered by an exposure to an intense trauma that threatens phys-
ical injury or death (with/without physical injury). Individuals
respond to an acute traumatic experience or cues associated
with the trauma with intense helplessness, fear or horror (DSM-
5; American Psychiatric Association, 2013). The manifestation
of this disorder is evident by the development and persistence
(over many months) of symptoms such as anxiety, diminished
extinction of conditioned fear, exaggerated startle response, and
cognitive impairments (Milad et al., 2009; Norrholm et al.,
2011). These re-experiencing and avoidance symptoms are fur-
ther compounded by the addition of other co-morbidities, such
as depression and substance abuse.
The clinical heterogeneity and large degree of overlap between
mTBI and PTSD, including the diagnosis of both conditions
either individually or co-morbidly, remains extremely challeng-
ing. Hitherto, most pre-clinical studies investigating response
to psychological trauma and biomechanical head injury have
remained largely separate focusing on both arms of the disor-
ders in isolation, with only a few studies attempting to address
the unique and overlapping features in a comorbid animal model
(McAllister and Stein, 2010). This strongly underscores the need
to develop a feasible and relevant translational pre-clinical model
that extrapolates the uni- or multi-dimensional hallmarks of both
disorders.
Of those that have exploited this vital relationship, intriguing
results have been reported. Kwon et al. (2011) investigated the
long-term consequences of unpredictable stress in the form of
fox-urine exposure, loud noises and sudden cage movements, in
combination with a blast injury induced by a compression-driven
shock tube. The observations revealed pronounced and sustained
impairment in memory function, neuronal and glial cell loss,
inflammation and gliosis in blast injured mice exposed to stress.
Similarly Elder et al. (2012) also examined rats with 3 repeated
blast injuries, and reported long lasting (>40 days) PTSD-related
behaviors, namely an impaired contextual fear conditioning,
exaggerated acoustic startle response, and anxiety-like behaviors.
Most recently, Klemenhagen et al. (2013) demonstrated a syn-
ergistic effect of repetitive concussive TBI and footshock stress
on social and depressive-like behavior. These reported changes
emphasize the need for mTBI and PTSD models, to recapitu-
late the sequence and hallmarks of the human condition. This
field of preclinical research is in its infancy, and important ele-
ments in model design have yet to be fully explored. For example,
the majority of studies have focused primarily on stress-trauma
exposure in combination with mTBI(s) at separate timepoints. In
this study we have tried to capitalize on combining a traumatic
event with a mTBI, because it models a large population of PTSD
patients (such as the combat veteran population) that experience
an emotional trauma at about the same time that they also expe-
rience TBI (Barnes et al., 2012; Bazarian et al., 2013). In addition
to this element, we have also tried to explore the effects of com-
bining a mTBI on a background of continuous unpredictable
repeated stress-trauma exposure as demonstrated by Kwon et al.
(2011). Finally, although most studies have focused on rat mod-
els of PTSD (Zoladz et al., 2008, 2012), we have utilized a mouse
model because of the potential future advantage of manipulat-
ing the genotype to explore factors that are implicated in the
development and expression of PTSD.
In this study we have used our previously developed model of
concussive injury, which has been extensively characterized from
24 h to 24 months post-injury (Mouzon et al., 2012, 2013; Ojo
et al., 2013). These mice show evidence of memory dysfunction
with repetitive mTBI, axonal injury, demyelination, white matter
(corpus callosum) thinning, and glial activation. This concus-
sive injury model was combined with a background of chronic
PTSD paradigm involving unpredictable predator odor expo-
sure (to trimethylthiazoline—TMT, a component of fox urine)
under restraint, and a conditioned footshock stimuli. We report
distinct and overlapping effects in neurobehavioral, neuropatho-
logical and biochemical profiles (in brain and plasma) in our
newly developed model at an acute time-point (14 days post-
exposure).
METHODS
ANIMALS: C57BL/6 MICE
Animals were purchased from Jackson Laboratories (Bar Harbor,
Maine). All mice used in this study were male, aged 10–12
weeks (average 25–26 g) and housed in standard cages under
a 12-h light/12-h dark schedule, at ambient temperature con-
trolled between 22 and 23◦C under specific pathogen free (SPF)
conditions. Animals were given food and water ad libitum and
maintained under veterinary supervision throughout the study.
Mice were randomly assigned to each of the four experimental
groups: mTBI alone, PTSD alone, mTBI+PTSD and control, with
an n of 11–13 per group. Experiments were performed in accor-
dance with OLAW andNIH guidelines under a protocol approved
by the Roskamp Institute IACUC. For a timeline of all exposures
and assessments see Figure 1.
TRAUMATIC STRESS EXPOSURE
Foot shock and unpredictable predator odor exposure(s) were
chosen as the means of aversive stimuli (stressors) for inducing
symptoms in accordance with each of the four clusters of the
DSM-5 criteria involving: intrusion, avoidance, negative alter-
ations in cognition and mood, and alterations in arousal and
reactivity (American Psychiatric Association, 2013).
For the predator odor we used exposure to Trimethyliazoline
(TMT) a component of fox feces/urine while animals were held
immobile in a decapicone restrainer. This concept of immobi-
lization was done in order to reproduce a mouse model analog
to the persistent feeling of helplessness, numbness and loss of
control, which are hallmark features of PTSD and critical in the
expression of the stress response (DSM-5; American Psychiatric
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FIGURE 1 | Timeline and procedures for the experimental mTBI and
PTSD paradigm. Mice were pre-trained to obtain their baseline fall latency
values on the rotarod test for motor co-ordination for 3 consecutive days, and
this was followed by a 7-day acquisition training in the radial arm water maze
(RAWM) test for spatial learning and memory. The 21 day experimental
paradigm involved an exposure to TMT and restraint on 11 randomly assigned
days (blue) at different times of the light-dark cycle. Around the midpoint, on
day 12, mice underwent fear conditioning, which involved being placed in a
conditioning chamber for 3min, exposure to a 70 db auditory cue for the last
30 s, culminating with 2 s of a 1mA foot-shock. Animals in the mTBI group
were exposed to a single concussive head injury 1 h after the foot-shock,
while under anesthesia. On day 21 animals were tested for their contextual
and cued fear memory response. This was followed by a battery of behavioral
tests for motor activity/coordination (rotarod), anxiety (elevated plus maze,
open field test), social behavior and spatial learning and memory (RAWM).
Brain tissue, plasma was collected for further studies.
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Association, 2013; Daskalakis et al., 2013). Within the 21-day
stress exposure period, animals received TMT exposures at 11
random timepoints during the light-dark cycle, for a period of
30min each session (see Figure 1). The element of sudden unpre-
dictability/randomness of exposure was designed to disrupt any
anticipation of the animal’s perceptive instinct to the stressor.
The long period of exposure (i.e., 30min) was designed because
human and animal studies suggest that prolonged exposure to
trauma increases the likelihood of developing symptoms of PTSD
(Zoladz et al., 2008; Zoladz and Diamond, 2013). The multiple
exposures were designed to force the animals to re-experience the
original stress response, thereforemimicking the repeated reliving
of intrusive traumatic memories experienced by human patients
(DSM-5; American Psychiatric Association, 2013; see also Zoladz
et al., 2008). This is in agreement with combat soldiers who
experience multiple traumatic experiences on the battlefield, and
show increased likelihood of developing PTSD symptoms (see
Vasterling et al., 2009; Daskalakis et al., 2013).
Fear conditioning was administered on day 12 at themid-point
of the 3-week stress paradigm. Briefly, this involved placing ani-
mals in a shuttlebox-chamber for 3min, with a pure tone (70 db)
introduced during the last 30 s. This tone intensity was chosen
based on optimization from a previous experiment showing a
minimal baseline (freezing) cued fear response to unstressed ani-
mals (Zoladz et al., 2008). At the end of the auditory cue, animals
received a single 1mA of uncontrollable/inescapable foot-shock
for 2 s, and were allowed to recover for 1min and then returned
to their home cages. Animals in the mTBI only and PTSD-mTBI
group received a single concussive brain injury 1 h after fear
conditioning (see below for mTBI procedure).
For retention of contextual/cued fear memory animals were
tested 9 days later. This involved exposing animals in the spa-
tial context for 3min and measuring the freezing response using
a video tracking system (Ethovision; Noldus—Netherlands). A
cued memory test was conducted 1 h after the contextual fear
memory test, and involved placing animals in a novel environ-
ment for 3min without the tone and a further 3min with the
tone. Freezing response was measured throughout the whole 6-
min period. Post-behavioral battery tests were conducted on days
22–34 (see Figure 1).
EXPERIMENTAL TBI PROCEDURE
The experimental TBI methods were performed as previously
described (Mouzon et al., 2012). Briefly, mice were anesthetized
with 1.5 L/min of oxygen and 3% isoflurane for 3min. After
shaving the injury site (around the anterior fontanelle), mice
were transferred into a stereotaxic frame (Just For Mice—TM
Stereotaxic, Stoelting, Wood Dale, IL) mounted with an electro-
magnetic controlled impact device (Impact-One TM Stereotaxic
Motorized Impactor, Richmond, IL). The head/skull was posi-
tioned in the device, which prevented lateral movements as the
impact was delivered. All mice were placed on a heating pad to
maintain their body temperature at 37◦C. A 5mm blunt metal
impactor tip attached to the electromagnetic motorized device
was zeroed on the scalp and positioned above the sagittal suture
midway before each impact using the NeuroLab controller. Upon
satisfactory positioning, the tip was retracted and the depth
adjusted to the desired level. The scalp was gently stretched by
hand to restrict lateralization of the impact and to prevent the
rod from delivering an inadequate trauma load at an irregular
angle. Injury parameters were 5m/s strike velocity, 1.0mm strike
depth, 200ms dwell time and a force of 72 N′′ (this paradigm was
developed specifically as a mild injury with no skull fracture or
subdural hemorrhage). Mice in the mTBI only and PTSD-mTBI
group received one single concussive hit, while those assigned to
the other groups received a single anesthesia of the same dura-
tion as their mTBI counterparts. After the impact was delivered,
mice were then allowed to recover on a heating pad set at 37◦C.
Upon becoming ambulatory, mice were returned to their cages
and carefully monitored for any abnormalities.
RADIAL ARMWATER MAZE (RAWM)
RAWM for spatial learning and memory was conducted as pre-
viously described by Park et al. (2008). This test was performed
on two separate occasions pre and post-stress/injury. The exper-
iment involved a radial arm water maze pool (120 cm diameter
and 30–40 cm height), containing six swim paths, which extend
from an open central arena, with an escape hidden platform
beneath the end of one target goal arm. Briefly, animals were
trained for 15 trials, which consisted of five blocks of 3 trials per
day (lasting for a period of 5–7 days) to locate the hidden goal
arm using visual cues located internally around the maze. Each
trial lasted for 60 s. Those animals that entered into an incorrect
arm were scored with an error (memory error score). The num-
ber of errors per block trial, across the entire length of the training
session was recorded using a video-tracking system (Ethiovision,
Noldus - Netherlands).
ROTAROD
Rotarod was conducted to evaluate sensorimotor coordination.
First mice were tested pre-stress/injury for their baseline rotarod
score i.e., ability to stay on a rotating rod for 3 × 5-min trials at
accelerating speeds of 5–50 rpm (on 3 consecutive days). On days
2, 5, and 11 after the last TMT exposure, mice were tested again as
previously (3 × 5min trials) for their sensorimotor coordination
(i.e., PTSD/mTBI related effects). The rotarod score, latency to
fall (0–300 s) was calculated by averaging the mean of the three
separate trials per day.
THREE CHAMBER TEST FOR SOCIAL INTERACTION AND NOVELTY
RECOGNITION TEST
The three chamber test quantifies the level of two social behaviors
(i.e., social interaction and social memory or novelty recognition)
between pairs of rodents. The test was conducted in a rectangu-
lar compartment that included a middle chamber with two doors
leading to two separate (left and right) chambers, each contain-
ing a steel cage enclosure. After 5min of habituation in the three
chamber compartment, each mouse (experimental subject) was
placed in the middle chamber and allowed to freely explore for
10min, with the right chamber empty but an unfamiliar congener
(Stranger I) held in the steel cage enclosure in the left cham-
ber. Social interaction was determined by measuring the number
of entries and length of time spent by the experimental subject
exploring the chamber holding the unfamiliar congener vs. the
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empty chamber, and also the frequency and duration of intrin-
sic behaviors that compose social interaction such as, sniffing,
allo-grooming, mounting. To measure social memory (or novelty
recognition) a new novel stimulus mouse (stranger II) was placed
in the enclosure in the previously empty right chamber and the
previous unfamiliar mouse (stranger I) was retained in the same
(left) chamber. The same parameters as above were measured to
determine the preference of the experimental subject for stranger
I and stranger II as an indication of social memory or novelty
recognition.
ELEVATED PLUS MAZE
The elevated plus maze is used to evaluate anxiety effects, based
on a rodent’s aversion of open spaces. The test consists of a plus
shaped apparatus with two open and two enclosed arms, each
with an open roof, elevated 50–70 cm from the floor. Each mouse
was placed at the junction of the four arms of the maze, fac-
ing the open arm. The mouse was allowed to maneuver freely
within themaze for 5min; number of entries and duration in each
arm (open/closed) were recorded with the aid of a video tracking
system.
OPEN FIELD TEST
The open field test is also used to evaluate anxiety effects. This test
was conducted in a large circular maze (120 cm diameter) setup in
a brightly lit room. Animals were placed in the center of the maze
and the number of entries/time spent in a predefined center zone
and around the walls of the maze was recorded over a 15min trial.
ELISA
To obtain hematological blood specimens suitable for measure-
ment of plasma glucocorticoid and cytokine(s) levels, animals
were lightly anesthetized with isoflurane prior to euthanasia,
and approximately 500μl of blood was withdrawn into EDTA
capillary tubes by cardiac puncture. Levels of glucocorticoids
are very sensitive and can fluctuate based on the light and dark
cycle of animals, environmental manipulations, and anticipa-
tion of food intake (McFall et al., 1992; Zoladz et al., 2012;
Zoladz and Diamond, 2013). In our study, we obtained levels
of corticosterone during the light cycle when levels are at their
lowest and while animals were completely undisturbed. This
timing was designed to avoid masking the potential rise in the
circadian rhythm of corticosterone levels during the dark cycles
with the true baseline levels of corticosterone. Samples were
centrifuged at 5000 rcf for 3min, and plasma samples (clear
supernatant fraction) were flash frozen in liquid nitrogen and
stored at −80◦C. Plasma glucocorticoid levels were measured
using an ELISA kit purchased from Life-sciences-Invitrogen,
Garand Island, NY. Cytokine levels (IL-6, IL-1β, TNFα, IL-17A,
IL-10, IFNγ) were determined using Bio-Plex Pro mouse Th17
panel ELISA kit (Biorad, Hercules, CA), as instructed by the
manufacturers manual.
BRAIN TISSUE PREPARATION ANDWESTERN BLOTTING
After the last post-behavior test on day 34, all animals were
deeply anesthetized with isoflurane before being intracardially
perfused by gravity drip with a heparinized phosphate buffered
solution (PBS) pH-7.4 for 3min. One hemisphere was collected
and flash frozen in liquid nitrogen and kept at −80◦C for
antibody based/biochemical analyses and the other hemisphere
was post-fixed in 4% paraformaldehyde (PFA) for histologi-
cal/immunohistochemical analyses.
For western blotting analyses, each half brain was homog-
enized in 750 ul PBS (pH 7.4) containing proteinase inhibitor
cocktail using a dounce homogenizer. Homogenized samples
were spun in a centrifuge at 15,000 rpm for 3min. Tissue super-
natants were collected and denatured by boiling in Laemmli
buffer (Bio-Rad, CA, USA) and resolved onto 4–20% gradient
polyacrylamide gels (BioRad, CA, USA). After electrotransfer-
ring onto polyvinylidene difluoride membranes, western-blots
were immunoprobed for different brain specific markers of neu-
rodegeneration: neurofilament L (NFL), phospho-tau serine-202
(CP13), glial fibrillary acidic protein (GFAP), and intracellu-
lar cell adhesion molecule -1 (ICAM-1). NFL (rabbit poly-
clonal anti-NFL, Millipore, Billerica, MA), CP13 (Peter Davies),
ICAM-1 (mouse anti-ICAM-1, Abcam, Cambridge, MA), and
GFAP (rabbit anti-GFAP, Dako, Carpentaria, CA). An anti-actin
mouse monoclonal antibody (Chemicon, CA, USA) was used as
a reference antibody to quantify the amount of proteins elec-
trotransferred, and NFL/actin, CP13/actin, ICAM-1/actin, and
GFAP/actin signal intensity ratios were quantified by chemilu-
minescence imaging with the ChemiDocTM XRS (Bio-Rad, CA,
USA).
IMMUNOHISTOCHEMISTRY
Hemispheres obtained from each mouse after transcardial perfu-
sion with PBS were post-fixed for >5 days in 4% paraformalde-
hyde, dehydrated in sucrose and weighed. 50 um thick coronal
sections were cut using a cryostat set at −17◦C (Leica, CM300,
Buffalo Grove, IL) throughout the whole rostro-caudal extent of
the cortex, hippocampus, and amygdala and stored in a 48 well-
plate containing cryoprotectant—30% sucrose and 30% ethylene
glycol. A 1 in 10 series of 5 separate sections through the regions
of interest guided by known bregma co-ordinates, was collected
for immunohistochemical (IHC) assessment of different mark-
ers. Briefly, standard IHC involved rinsing free-floating sections
in deionized water and subsequently incubating sections at room
temperature in a solution of endogenous peroxidase blocking
solution, containing 3% hydrogen peroxide and 10% methanol
diluted in deionized water for 30min. After rinsing, sections were
treated with target retrieval citrate buffer solution (pH 6) for
30min at 90◦C (if recommended) to induce heat mediated anti-
gen retrieval. Further incubation with either protein block serum
free solution (Dako Carpinteria, CA) or 0.01% Tween 20 in PBS
containing 10% normal serum solution to which the secondary
antibody was raised (Vectors lab, Burlingame, CA), was carried
out for a period of 1 h at room temperature depending on the
antibody used.
Sections were stained in entire batches with primary antibod-
iesmade up in either antibody diluent background reducing agent
from DAKO or 1% normal serum. Primary antibodies used were
raised against:
(i) GFAP (rabbit anti-GFAP, 1:25,000, Dako, Carpinteria, CA)
for astrocytosis.
(ii) CD45 (rat anti-mouse CD45, 1:1000, Serotec, Raleigh, NC)
for microgliosis.
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(iii) Doublecortin, DCX (rabbit anti-DCX, 1:1000, Abcam,
Cambridge, MA) for immature neurons.
(iv) c-Fos (rabbit anti-cFos, 1:1000, Millipore, Billerica, MA)
immediate early gene cFos.
(v) Laminin (rabbit anti-Laminin, 1:25, Sigma, St Louis, MO)
for blood vessels.
(vi) Synaptophysin (rabbit anti-SYN, 1:50, Dako, Carpinteria,
CA) for synapses.
(vii) ICAM-1 (rabbit anti-ICAM-1, 1:800, Santa Cruz, Dallas,
TX) for inflammation.
(viii) Iba1 (goat polyclonal anti-Iba1, 1:2500, Abcam,
Cambridge, MA) for microglia.
After overnight incubation with the relevant primary antibodies,
sections were rinsed with PBS, transferred to a solution contain-
ing the appropriate secondary antibody (from the Vectastain Elite
ABC Kit, Vector Lab, Burlingame, CA) diluted in 0.01% Tween
20 containing 1% normal serum for 1 h, and further incubated
with avidin- biotin-horseradish peroxidase solution (Vectastain
Elite ABC kit; Vector Lab, Burlingame, CA) for a further hour.
Immunoreactivity was visualized with 3,3′′-diaminobenzidine
(DAB) chromogen. Development with the chromogen was timed
and applied as a constant across batches to limit technical vari-
ability (in immunodetection) before progressing to quantitative
image analysis. The reaction was terminated by rinsing sections
in distilled water. Finally, mounted sections counterstained in
hematoxylin, were progressed through a graded series of alcohols
(dehydrated), cleared in xylene and coverslipped with perma-
nent mounting medium. Negative control sections were included
whereby the primary antibody was omitted and replaced either
with blocking agent or biotinylated secondary antibodies alone.
Immunoreacted sections were viewed using an Olympus BX63
light microscope with a high resolution DP72 camera (Olympus,
Center Valley, PA).
IMAGE ANALYSIS
Immunoreactivity for (GFAP, IBA1) cell markers was mea-
sured by quantitative image analysis (optical segmentation).
Rigorous staining protocols were applied to ensure consistency of
immunostaining and accuracy of image analysis. This procedure
was performed by blinded assessment (with each slide analyzed
blind with respect to marker or animal group). Firstly, a survey
of immunoreacted tissue sections was performed independently
to verify specific immunoreactivity in each series (∼1 in 10) of
sections that was subsequently progressed to quantitative image
analysis. Briefly, non-overlapping RGB (red, green, blue) images
were digitally captured randomly within the defined areas from
each section (comprising an average of 5 sections per animal for
each region andmarker), providing a randomized-systematic sur-
vey of each region throughout the area of interest for each animal.
A total area of 0.65mm2 microscopic field (captured at ×60)
was analyzed for each region per animal. For both cellular mark-
ers we analyzed the corpus callosum (CC), parietal cortex region
beneath the injury site, hippocampus (CA1–CA3), the basolateral
amygdala, and the medial and periventricular hypothalamus (in
regions bound by the bregma co-ordinates −0.94 to −2.75). Due
to the limited number of serial sections we were unable to analyze
the distinct subnuclei within the hypothalamus separately, focus-
ing primarily on nuclear regions primarily involved in controlling
aspects of stress-related endocrine functions. We omitted the lat-
eral hypothalamus because it has a lesser role in stress-related
endocrine functions.
Immunoreacted profiles that were optically segmented were
analyzed using FIJI-Image J morphometric image analysis soft-
ware. A semi-automated RGB color threshold function was
employed to determine the optimal segmentation (threshold set-
ting) of immunoreactivity for each antibody. Deconvolution was
performed on counterstained sections to subtract the background
counterstain. Immunoreactive profiles discriminated in this man-
ner were used to determine the specific mean immunoreactive
area of staining. Data were separately plotted as the mean per-
centage area of immunoreactivity per field (denoted “% Area”) ±
SEM for each region and grouping.
To determine changes in doublecortin immunoreactive (ir)
cell counts in the DG, a 1 in 10 series averaging >5 sections
was chosen in a random systematic manner through the region
of interest. Doublecortin-ir cell somata were easily discriminated.
An average of the total number of DCX+ cells in the dentate gyrus
(DG) of the hippocampus of each of the five separate sections
containing the hippocampal portion was determined.
VOLUMETRIC ESTIMATES
The volume of the right hippocampus as guided by bregma co-
ordinates (−0.94 to −3.28mm) and the corpus callosum (bound
by bregma co-ordinates −0.94 to −2.30mm) was determined
by quantitative light microscopy using the Cavalieri method as
described elsewhere (Ojo et al., 2011). In brief, rostrocaudal sec-
tions from the extent of the right hippocampus of each animal
(taking every sixth serial section) were mounted onto superfrost
plus slides, after washing with 0.1M PB at pH 7.4 to remove
the cryoprotectant storage solution. An average of 12–15 sec-
tions were collected per animal. Mounted sections were air-dried
and stained with a solution of 0.1% cresyl fast violet (Tedpella,
Reading, CA) and were viewed at lowmagnification using a DP72
digital camera attached to a motorized Olympus BX63 digital
photomicroscope (Olympus, Center Valley, PA). Analyses were
carried out blind and were made via the Cell SENS Olympus soft-
ware package. Digital images were captured electronically and the
boundaries of the total hippocampal compartment and corpus
callosum in the region of the injury site (bound by bregma co-
ordinates −0.94 to −2.30mm) were digitally outlined on each
section from the series of rostro-caudal sections of the right hemi-
sphere. For each animal, the total volume of the right hippocam-
pus and corpus callosum (bound by bregma co-ordinates −0.94
to −2.30mm) was subsequently derived by multiplying the cal-
culated total surface area by the mean distance between the
series of sections. Data are presented as mean volume (in
mm3) ± SEM.
STATISTICAL ANALYSIS
Data were tested for normal (or Gaussian) distribution using the
D’Agostino and Pearson omnibus K2 normality test for skew-
ness and kurtosis. Homogeneity of variance was tested using
the Browns-Forsythe and Bartlett’s test. An alpha criterion level
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of P < 0.05 was set for all statistical significance. Analyses were
performed using the Graphpad prism software (LaJolla, CA).
Neurobehavior
Overall mean percent freezing values during the contextual fear
memory test, mean errors on the final day of RAWM training
and mean time in center zone during open field test were ana-
lyzed using One-Way analysis of variance (ANOVA). A regular
Two-Way ANOVA was used to analyze the overall mean per-
cent freezing values during the cued fear memory test with the
two subject factors of cued-tone and exposure groups/paradigms.
Repeated measures-Two Way ANOVA was used to analyze con-
textual fear memory, cued fear memory, RAWM memory errors,
rotarod, open field center zone entries and motor activity data,
with the two subject factors of “group exposure” and a repeated
within subject factor of “time blocks” across the trial or train-
ing session of each test. Tukey’s post-hoc test was performed
when appropriate. Elevated plus maze data did not fit the normal
(or Gaussian) distribution and were analyzed with the non-
parametric Kruskal Wallis One-Way ANOVA test followed by
Dunn’s correction for multiple testing. Social interaction and
social novelty recognition data for each group exposure were ana-
lyzed using theMannWhitneyU-test for the dependent measures
of time spent between stranger I and stranger II chambers.
Biochemistry and histopathology
Following normality testing, biochemistry data (corticosterone,
cytokine profiles, brain injury biomarkers) and histopathological
data (brain weight, hippocampal and corpus callosum volumes
and doublecortin cell counts) were analyzed using the non-
parametric Kruskal Wallis One-Way ANOVA test followed by
Dunn’s correction for multiple testing where appropriate. GFAP
and IBA1 immunoreactivity data (per brain region) were ana-
lyzed using One-Way ANOVA.
RESULTS
CONTEXTUAL AND CUED FEAR MEMORY RESPONSE AND SPATIAL
LEARNING AND MEMORY PERFORMANCE IN A MOUSE MODEL OF
mTBI-PTSD
Interactions between mTBI and PTSD were examined on contex-
tual and cued fear memory response 9 days after fear conditioning
induced by a 1mA footshock and 70 db auditory cue. One-Way
ANOVA showed a significant main effect across the study groups
in the context over the 3min trial session [F(3,30) = 5.875; P =
0.003; Figure 2A1). This effect was also observed when the data
for each trial session were broken into 30-s blocks. A repeated
Two Way ANOVA showed a significant main effect across the
study groups [F(3, 30) = 5.432; P = 0.004], no significant main
effect was observed on the variance over time blocks [F(5, 150) =
2.207; P = 0.057], and a significant interaction between the study
groups and variance over time blocks was observed [F(15, 150) =
1.749; P = 0.047; Figure 2A2]. Tukey’s post-hoc analysis of the
freezing response over the 3-min trial showed a significant
effect between control and PTSD groups only (P = 0.0016;
Figure 2A1). While post-hoc analysis of freezing over 30 s blocks
was shown to be significant between control and PTSD groups
at the fourth and last block periods (P = 0.0005; P = 0.0003
respectively—Figure 2A2), mTBI abrogated the PTSD induced
fear response to the context, and post-hoc analysis showed no
significant effect between mTBI-PTSD and controls over the
3-min trial and also (variance) across 30 s blocks (P > 0.05;
Figures 2A1,A2).
Two-Way ANOVA of the cued fear response for the 6-min
trial session showed a significant main effect across the study
groups (exposure paradigms) [F(3, 90) = 10.47; P < 0.0001], and
a significant main effect of time during the introduction of the
auditory cue [F(1, 90) = 47.52; p < 0.0001]. A main interaction
was also observed between the study groups and time during
exposure to the auditory cue [F(3, 90) = 8.791; P < 0.0001—
Figure 2B1]. A repeated measures Two-Way ANOVA conducted
over 30 s blocks, over 6min of the trial, showed a significant main
effect across the study groups [F(3, 45) = 8.190; P = 0.0002], and
of variance across time blocks [F(11, 495) = 36.07; p = 0.0001].
A main interaction was also observed between the study groups
and variance across time blocks [F(33, 495) = 6.908; P = 0.0001—
Figure 2B2]. Tukey’s post-hoc multiple comparisons test showed
a significant effect in percent freezing time between control vs.
PTSD (P = 0.004) and control vs. mTBI-PTSD over the 6-min
trial (P = 0.005; Figure 2B1). This significant effect was observed
following correction for multiple testing during the seventh to
tenth block periods when mice were exposed to the auditory cue
(P < 0.0001 in pair wise comparisons between control vs. PTSD
and control vs. mTBI-PTSD; see Figure 2B2). Our data indicate
that mTBI did not abrogate the freezing response to the cue in the
mTBI-PTSD exposed animals.
For evaluation of spatial learning and memory, mice were
trained for seven consecutive days prior to the induction of both
mTBI and PTSD. All mice performed similarly in the pre-training
seven days trial session, reaching the set criteria of one memory
error (Figure 2C1). Repeated measure Two-Way ANOVA showed
a significant main effect of time [F(34, 952) = 31.41; P ≤ 0.0001]
indicating an improvement in the rate of learning over the seven
day training period. No significant effect was observed across the
study groups [F(3,29) = 2.181; P = 0.113].
Deficits in retrograde amnesia were assessed 1 week after the
last TMT exposure and 2 weeks after the last mTBI insult, in a
5-day acquisition-training paradigm. A repeated measures Two-
Way ANOVA showed no significant main effect across the study
groups [F(3, 28) = 1.357; P = 0.276]. A significant effect of time
was observed [F(24, 672) = 7.131; P < 0.001], indicating that the
mice showed improvements in the rate of learning through-
out the training session. No significant interaction was observed
between time and study groups [F(72, 672) = 0.942; P = 0.615—
Figure 2C1]. Examination of the average memory errors on the
last day of the training session also showed no significant effect
following One-Way ANOVA [F(3, 27) = 0.617; P > 0.05].
Our data therefore failed to demonstrate any significant effect
of mTBI or PTSD or their combinations on spatial learning and
memory performance (Figures 2C1,C2).
ANXIETY AND SOCIAL BEHAVIORS IN A MOUSE MODEL OF PTSD-mTBI
We investigated the effects of mTBI and PTSD on anxiety related
behaviors using the elevated plus maze and the open field
tests. Our observations from the elevated plus maze showed a
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FIGURE 2 | Contextual, cued fear, and spatial memory. PTSD animal group
showed a significant increase in their (%) freezing responses to both the
context (A1,A2) and the auditory cue (B1,B2), compared to control animals.
mTBI inhibited the retrieval of the contextual fear memory response in the
mTBI-PTSD group (A1,A2), there was no effect of mTBI on the cued fear
response in the mTBI-PTSD group (B1,B2). No significant effect was seen in
the fear memory response from the mTBI only group compared to the control
group in both the context and with the auditory cue (P > 0.05; n = 8–13). All
animals performed equally in the pre-training session in the RAWM test,
reaching the training criteria of one-memory errors by the end of the 7-day
acquisition training session (C1). Two-way analysis with repeated measures
showed no main effect of exposure (and their interaction with time; P > 0.05)
with either PTSD, mTBI or their combinations on spatial learning and memory
(Continued)
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 213 | 8
Ojo et al. Mouse model of PTSD and concussion
FIGURE 2 | Continued
of a pre-learned task (C1) (n = 8–9). No effect was seen on mean memory
error during the last day of the trial (C2). Data are presented as mean ± SEM.
X-axis in (A2,B2) represent 30 s and 0.5min (time) epochs over the entire
length of the trial. Data in (A1,C2) were analyzed using One-Way ANOVA.
Data in (B1) were analyzed using a regular Two-Way ANOVA. Data in
(A2,B2,C1) were analyzed using a repeated measures-Two Way ANOVA.
Tukey’s multiple comparisons post-hoc test was performed in all cases.
Asterisks denote statistical significance as follows: ∗∗P < 0.01;
∗∗∗P < 0.001.
significant main effect across the study groups (experimental
paradigms) with respect to the time spent in the open arms
(P = 0.015; Kruskal Wallis One-Way ANOVA) and entries into
the open arms (P = 0.017; Kruskal Wallis One-Way ANOVA, see
Figures 3A,B). PTSD mice spent on average 50% less time (and
made 50% fewer entries) in the open arms compared to con-
trols, however this trend was not statistically significant following
multiple test correction (Dunn’s) (P > 0.05), owing possibly to
the large variation within the groups (Figures 3A,B). mTBI and
mTBI-PTSD mice spent 35–50% more time (and entries) in the
open arms compared to control mice and 70%more compared to
PTSD only group. After correction for multiple testing, this was
only significant in the combined mTBI-PTSD group compared to
PTSD alone for both time (P = 0.007) and frequency (P = 0.009)
of open arm entries (Figures 3A,B).
In the Open field test, analysis of center zone entries showed
a significant main effect across the study groups [F(3, 45) = 5.94;
P = 0.002] and time [F(4, 180) = 17.91; P = 0.0001], as deter-
mined by repeated measures Two-Way ANOVA (Figure 3C). No
interaction was observed between the study groups and time
[F(12, 180) = 0.768; P = 0.683], indicating a consistency in behav-
ior throughout the entire session across the groups, and irrespec-
tive of time. One-Way ANOVA of the center zone entries over
the entire 15min trial showed a significant main effect across the
groups [F(3, 45) = 6.32; P = 0.001], Tukey’s post-hoc test showed
a significant effect between control vs. PTSD (P = 0.004) and
control vs. mTBI groups (P = 0.002; Figure 3C). These data indi-
cate an increase in aversion for open space(s) in both PTSD and
mTBI exposure groups compared to controls (Figure 3C). These
traits were also present despite all animals having a comparable
motor activity (Figure 4A). Repeatedmeasures Two-Way ANOVA
showed a significant effect on variance across the time blocks
[F(4, 180) = 49.55; P < 0.0001], with no effect observed across the
study groups [F(3, 45) = 1.14; P = 0.344], neither was there any
interaction between study groups and variance across time blocks
[F(12, 180) = 0.844; P = 0.605].
Analyses of the open field center zone entries over time blocks
showed that the combined mTBI-PTSD groups behaved dis-
tinctly different in comparison to mTBI or PTSD only groups,
in that they demonstrated a consistent increase in mean num-
ber of entries into the center zone throughout the 15min trial
session (Figure 3C). Unlike the mTBI or PTSD only groups,
no significant effect was observed between mTBI-PTSD vs.
control following post-hoc Tukey’s multiple comparisons test
(P > 0.05).
With respect to time spent in the center zone, One-Way
ANOVA showed a significant main effect across the groups
[F(3, 45) = 3.396; P = 0.026], however following post-hoc Tukey’s
test the reduction in time spent was only significant in the PTSD
only group compared to controls (P = 0.024; Figure 3D).
Social behavior was assessed using the social interaction test
and the social novelty recognition test based on the tendency of
mice to respond to novel objects. Our observation shows that
controls (P = 0.038) and, intriguingly, mTBI-PTSD (P = 0.002)
mice demonstrated normal rodent social interaction behavior,
spending significantly more time exploring the stranger mouse
than the empty chamber (Figure 3E). However, the mTBI (P =
0.323) and PTSD (P = 0.387) only groups exhibited a deficit
in social interaction behavior, as they failed to interact longer
with the new stranger mouse than the empty chamber/cage
(Figure 3E). In the social novelty test only the PTSD (P = 0.214)
animals showed a significant deficit in their preference for the new
novel stranger mouse over the old familiar mouse (Figure 3F).
PTSD AND mTBI EFFECTS ON MOTOR ACTIVITY AND BODY WEIGHT
A significantmain effect of time was observed onmotor activity as
measured by Open field test [F(4, 180) = 49.55; P < 0.0001] and,
motor coordination as measured by the rotarod test [F(2, 58) =
3.523; P = 0.036] following analysis by repeated measure Two-
Way ANOVA (Figures 4A,B). This demonstrates a change in
mobility with time during the open field test and an improve-
ment in rotarod performance over time epochs. However, we
observed no effect of either PTSD and/or mTBI on motor activity
[F(3, 45) = 1.137; P = 0.344], or motor coordination [F(3, 29) =
2.42; P = 0.100]; all animals performed similarly, thus indicating
a relatively intact motor function (Figures 4A,B). No interaction
was observed between study groups and time on the motor activ-
ity measured by the open field [F(12, 180) = 0.844; P = 0.605]
and motor coordination measured by the rotarod test [F(6, 58) =
1.047; P = 0.405]. In the PTSD only group we observed a reduc-
tion in growth rate (∼5%) between the beginning and end of
the 3-week stress exposure session, possibly indicating trauma-
induced hypophagia, however this was not statistically significant
(Figure 4C).
NEUROENDOCRINE AND NEUROIMMUNE SYSTEMIC PROFILES IN
mTBI-PTSD MODEL
We investigated the baseline plasma levels of the neuroen-
docrine stress-related hormone corticosterone and observed a
trend toward an increase in plasma levels in both PTSD and
PTSD-mTBI mice, however this was not statistically significant
(P < 0.05; Kruskal Wallis One-Way ANOVA; Figure 5).
Classical T-lymphocyte pro-inflammatory cytokines(s),
namely Th1 (IL-1β, IL-6, TNFα, IFNγ) and Th17 (IL-17A)
cytokines and the T regulatory anti-inflammatory cytokine
(IL-10) were assayed using a multiplex ELISA assay kit. Our
observation shows a significant main effect across the groups
on TNFα plasma levels (P = 0.036; Kruskal Wallis One Way
ANOVA), which was still evident in PTSD only mice compared
to controls after correction for testing (P = 0.036; Figure 6C).
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FIGURE 3 | Elevated plus maze, open-field, and social behavior. Elevated
plus maze; PTSD only group spent 50% less time on average in the open
arms compared to control, however this trend was not significant (P > 0.05)
following multiple comparisons test (A). Animals that received mTBI spent
relatively more time and number of entries into the open arm compared to
control and PTSD only groups (A,B). This comparison was shown to be
statistically significant between the PTSD and mTBI-PTSD groups (P < 0.05).
Data in (A,B) were analyzed using non-parametric Kruskal Wallis-One Way
ANOVA followed by Dunn’s correction for multiple testing. Open field test
demonstrated a statistically significant reduction in mean center zone entries
over the 15min trial (P < 0.01) in both mTBI and PTSD animals compared to
control (C). However there was a noticeable trend in the behavior of
mTBI-PTSD animals, compared to PTSD only and mTBI only animals. The
latter showed an increased mean number of entries into the center zone,
although this was not statistically significant (P > 0.05) compared to the
other groups (C). Only the PTSD group showed a significant reduction in the
mean total time spent in the center zone over the 15-min trial compared to
control (P < 0.05). These data were evident despite the fact that all groups
demonstrated a comparable motor activity in the open field test (see
Figure 4A). Data in (C) were analyzed using repeated measure-Two Way
ANOVA with Tukey’s post-hoc test, and data in (D) by One-Way ANOVA
followed by Tukey’s post-hoc test. Social behavior was measured in the social
interaction/recognition test (E,F). mTBI and PTSD only groups showed no
significant distinction between the time spent in the “empty” and “stranger
I” chamber (E). Control and mTBI-PTSD animals performed similarly in the
social interaction test (E). In the social recognition test PTSD only animal
group also did not show any distinction between “stranger I” and “stanger
II” chambers, indicating a dysfunction in social memory and preference (F).
mTBI only and mTBI-PTSD animal groups performed similarly as the control
group (F). Data are presented as mean ± SEM. Data in (E,F) were analyzed
using non-parametric Mann Whitney U-test for each group. Asterisks denote
statistical significance as follows: ns; not significant; ∗P < 0.05; ∗∗P < 0.01;
∗∗∗P < 0.001. N = 11–13 in all behavioral tests, except in the social
interaction test (n = 6–8).
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FIGURE 4 | Motor activity/coordination and growth rate. No main effect
was observed in the motor activity during the open field test, and motor
coordination in the rotarod test in any of the groups (A,B). Data in (A,B)
were analyzed using repeated—Two Way ANOVA followed by post-hoc
Tukey’s test (n = 11–13). Mice in the control, mTBI, and combination groups
showed a 2–5% increase in body weight over the 21 day stress
experimental paradigm, while PTSD only mice showed a 5% reduction in
their body weight (C). Data are presented as mean ± SEM.
Consistently there was also a trend toward increase in the lev-
els of IL-1β, IL-6, and IFNγ in PTSD only mice, however this
was not statistically significant following Kruskal Wallis One-Way
ANOVA (P > 0.05; Figures 6A,D,F).
In contrast, IL-17A plasma levels showed a significant main
effect across the groups (P = 0.022; Kruskal Wallis One-Way
ANOVA), and multiple comparisons test showed a significant
increase in the Th17 cytokine (IL-17A) levels in mTBI-exposed
mice compared to control (P = 0.016; Figure 6E). Interestingly,
PTSD mitigated this rise in IL-17A levels in the PTSD only and
FIGURE 5 | Neuroendocrine response to mTBI and PTSD. Plasma
baseline levels of corticosterone showed a trend toward increase in PTSD
and mTBI-PTSD only animals (> +70 ng/ml) compared to control. This trend
did not reach statistical significance after analyses with Krukal Wallis-One
Way ANOVA followed by Dunn’s correction for multiple testing. mTBI
animals showed a similar baseline level of corticosterone as controls. Data
are presented as mean ± SEM. (N = 4–5).
combined mTBI-PTSD model compared to controls (P > 0.05).
Levels of the T regulatory cytokine 1L-10 showed a trend toward
an increase in the PTSD group, but were not statistically signif-
icant compared to controls (P > 0.05; Kruskal Wallis One-Way
ANOVA; Figure 6B).
GROSS PATHOLOGICAL CHANGES TO THE BRAIN(S) OF ANIMALS
EXPOSED TO PTSD AND/OR mTBI
Post-fixed brain hemispheres were weighed to determine any
gross neuropathological outcomes; there was no observed effect
of either PTSD or mTBI or both on brain weight (P > 0.05
Kruskal Wallis One-Way ANOVA—Table 1). We also did not
observe any changes in hippocampal volume with mTBI or PTSD
or both (P > 0.05; Kruskal Wallis One-Way ANOVA—Table 1).
Consistent with our previous findings from a later timepoint
(at both 6 and 12 months post-injury) in mice receiving a sin-
gle mTBI (Mouzon et al., 2013), there was a notable reduction
(<20%) in the volume of the corpus callosum in the mTBI and
combined groups, however this was not statistically significant
(P > 0.05 Kruskal Wallis One-Way ANOVA—Table 1).
EFFECT OF mTBI AND PTSD ON MARKERS OF EARLY BRAIN INJURY
Markers of axonal injury (NFL), astroglial activation (GFAP),
inflammation (ICAM-1), and phospho-tau (CP13) were assessed
in half brain homogenates by immunoblotting. We observed no
significant change in GFAP and pTau levels globally in the brain
(P > 0.05; Kruskal Wallis One-Way ANOVA—Figures 7B,D).
Notably, axonal NFL (P = 0.022) and inflammatory ICAM-1
(P = 0.016) markers were significantly increased in the combined
mTBI-PTSD groups compared to controls (Figures 7A,C). No
effect was seen with mTBI or PTSD alone compared to controls,
on both NFL and ICAM-1 levels (P > 0.05; Figures 7A,C).
IMMATURE NEURON CELL COUNTS IN THE DENTATE GYRUS
FOLLOWING PTSD AND/OR mTBI
Doublecortin levels (a marker of immature neurons) were
assessed in the dentate gyrus as an indicator of impaired
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FIGURE 6 | Immune/inflammatory systemic response at acute
time-point post-mTBI-PTSD. Levels of 6 different cytokines (IL-1β, IL-10,
TNFα, IL-6, IL-17A, IFNγ) were measured in the plasma to detect
systemic immune/inflammatory responses to mTBI and/or PTSD. There
was an obvious trend toward increase in IL-1B, IL-10, TNFα, and IL-6 in
PTSD only animals compared to control and mTBI groups, however this
was only statistically significant with TNFα (P = 0.036) and a marginal
trend with IL-1β (P = 0.06) (A–D). Intriguingly we observed a rise
(P = 0.049) in IL-17A in mTBI only animals compared to controls (E).
No significant effect was seen in the levels of IFNγ amongst the
different groups (F). Data are presented as mean ± SEM. Data in
(A,B,D–F) were analyzed with Kruskal Wallis-One-Way ANOVA followed
multiple testing. Asterisk denote statistical significance as follows:
*P < 0.05. (N = 4–5).
neurogenesis/neuronal differentiation. No significant effect was
seen between the groups (P = 0.598; Kruskal Wallis One-Way
ANOVA), indicating no effect on adult neurogenesis at this acute
time point with exposures to mTBI, PTSD or their combination
(Figure 8).
ASTROGLIAL AND MICROGLIAL CELL ACTIVATION
A One-Way ANOVA followed by a post-hoc comparisons test
was performed on percent immunoreactivity area per region for
cellular markers IBA1 and GFAP.
We observed a significant increase in IBA1 levels (P = 0.01) in
the corpus callosum region following post-hoc analysis between
mTBI compared to controls (Figures 9A–D,V). No significant
effect was observed in the other regions (P > 0.05).
A robust increase in GFAP levels was also observed fol-
lowing post-hoc analysis in the corpus callosum of mTBI
(P = 0.038) and mTBI-PTSD (P = 0.009) groups compared to
controls (Figures 9E–H,U). mTBI also significantly increased
GFAP immunoreactivity in the hippocampus (P = 0.022) and
cortical region beneath the injury site compared to controls
(P = 0.034; Figures 9J,L,U). These mTBI dependent effects were
not consistently observed in the combined mTBI-PTSD groups
compared to controls (Figure 9U). No effect was observed on
GFAP immunoreactivity in the hippocampus of PTSD alone ani-
mals (Figures 9I,K,U). Increased GFAP immunereactivity was
also present in the hypothalamus and basolateral amygdala of
animals that received PTSD alone or combination with mTBI
(Figures 9M–T,U). However, post-hoc analysis of the densitome-
try data showed a significant effect only in the mTBI-PTSD group
compared to controls in the basolateral amygdala (P = 0.006). A
marginally significant trend was observed in the PTSD only group
vs. controls within the BLA (P = 0.071).
DISTINCT NEUROGLIAL ANDWHITE MATTER RESPONSE(S) TO mTBI
We observed an increase in astroglial activation in themost super-
ficial layer of the cortex and notably around perivascular regions
of injuredmice, in bothmTBI and combinedmTBI-PTSD groups
(Figures 10A–D). These astroglial cells exhibited a hypertrophic
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Table 1 | Gross neuropathological changes in the brain.
Control mTBI PTSD mTBI-PTSD
Brain weight
(mg)
0.23± 0.01 0.22± 0.01 0.24± 0.003 0.23± 0.02
Hippocampi
(mm3)
10.28± 0.57 9.41± 0.20 9.92± 0.61 9.21± 0.29
Corpus callosum
(mm3)
0.92± 0.12 0.69± 0.05 0.82± 0.10 0.71± 0.08
Post-fixed brains were weighed prior to immunohistochemical and histological
analyses. All groups had a relatively similar wet brain weight, no significant differ-
ence was observed between the groups (P > 0.05). Hippocampal and overlaying
corpus callosum volumes (see Methods for bregma boundaries) were measured
using the Cavalieri “stereology principle.” Hippocampal volume was relatively
similar in all groups, no statistically significant changes were observed between
the groups. There was a subtle change in the volume of the corpus callosum in
mTBI and mTBI-PTSD groups compared to controls (∼20% volume reduction).
However this was not statistically significant following post-hoc comparisons
test. Data are presented as mean ± SEM. Data (brain weight and regional vol-
umes) were analyzed with Kruskal Wallis-One-Way ANOVA followed by Dunn’s
correction for multiple testing. (N = 4–5).
cell somata and short thickened cellular processes (for compari-
son; see control resting astroglia in Figures 9A,E,I,M,Q). In the
lining of the ventricles and the surrounding white matter we
found a robust activation of what appeared to be hypertrophic
(type-2) astroglial cells (Figures 10E,F) also demonstrating the
typically large cell somata and short thick processes.
In the corpus callosum we noticed a reduction in the
immunoreactivity levels of extracellular matrix protein marker
laminin in injured mice (Figures 11A–D). Microglial cells
(IBA1+ and CD45+) were also activated in other focal regions
of the white matter (optic tract) and neighboring regions of
injured mice (Figures 11E–J). In addition to the above histomor-
phological profiles, we observed ICAM1+ cells dispersed mul-
tifocally throughout some white matter regions in injured mice
(Figures 11K,L), they appeared to resemble oligodendroglia-like
cells (and in some cases microglial cells—see inset Figure 11K).
These aforementioned histomorphological changes were compar-
atively similar in both mTBI andmTBI-PTSD groups; no changes
were observed in the PTSD only group. PTSD did not seem
to augment these changes in the combination group, therefore
indicating a distinct response to mTBI.
DISCUSSION
DISTINCT NEUROBEHAVIORAL PATTERNS OF mTBI-PTSD MICE
At the outset of this study our goal was to develop and charac-
terize a novel model of PTSD in conjunction with our recently
developed mTBI model, in order to provide a preclinical platform
with which to explore the relationship between mTBI and PTSD
at the neurobehavioral, neuropathological and molecular level.
With respect to the neurobehavioral outcomes, we hypothesized
that an exposure to a traumatic event coupled with a concus-
sive head injury would induce an additive significant impairment
in the consolidation and/or retrieval of memory from a previ-
ously learnt task. We tested this hypothesis by training animals
in a rigorous RAWM test paradigm, but 2 weeks after the last
exposure to a stressful traumatic event and/or 24 days after a
concussive head injury, all animals demonstrated an intact con-
solidation, retrieval and recall of memory from the previously
learnt task in the RAWM. Previous studies have documented
the effects of TBI or PTSD on memory processing in both ani-
mal and human models (Gronwall and Wrightson, 1974; Levin
et al., 1976; Bremner et al., 1993; Vasterling et al., 1998; Diamond
et al., 1999, 2004, 2005, 2007; Sandi and Pinelo-Nava, 2007;
Mouzon et al., 2012, 2013). With respect to mTBI animal models,
including the paradigm employed here, injury related cogni-
tive deficits in both retrograde and anterograde amnesia have
been documented in various permutations of cognitive tests such
as Morris water maze, and the Barnes maze, from 1 week to
several weeks after injury (Smith et al., 1994; Bramlett et al.,
1997; Mouzon et al., 2012, 2013). However in rodent models of
stress-trauma, there have been some mixed results. For example,
Diamond and colleagues demonstrated that an unpredictable
traumatic, stressful exposure to a predator is able to impair the
consolidation and/or retrieval of memories outside the stressful
environment, such as the location of a hidden platform in the
water maze, 30min–24 h post-exposure (Diamond et al., 2004,
2005, 2007), and this has been confirmed in a host of different
stress-trauma animal models—(see Joels et al., 2006 for review).
However when animals were tested at a later time-point (3 weeks
post-stress) following exposure to two episodes of psychosocial
stressors, the same authors failed to see a significant deficit in
learning and memory processes in the RAWM (Zoladz et al.,
2008).
In contrast to the above findings, our data suggest that stress-
trauma and/or single mTBI alone or in combination do not
reproduce long-lasting spatial and learning memory deficits (1–
3.5 weeks respectively). Previously, in our concussive single head
injury model, although we detected impairment in learning
acquisition 5–7 days post-injury in the Barnes maze test, this ini-
tial deficit was resolved by 6 months post-injury (Mouzon et al.,
2012, 2013). It is thus likely that any mTBI-induced deficits in
learning and memory in our model were time-dependent and
sensitive and, as such, due to the time-elapsed post-trauma and
the mild nature of the concussive injury we were unable to detect
these behavioral outcomes. In addition to this, we also consider
that the highly rigorous training schedule giving to the animals
prior to the stress and concussive head injury paradigm might
have been counterproductive and precluded detection of some
of the subtle effects in response to trauma and head injury. This
behavioral pattern has been suggested by Cain et al. (1997) and
demonstrated in rodents pre-trained in a Morris water maze
(MWM) task. These animals were resistant to show impairment
in a subsequent MWM task even after receiving a NMDAR antag-
onist (CGS-19775) and were able to learn the spatial location of
the hidden platform at the same level as controls (see also Cain,
1997).
Despite this lack of change in the retrieval, consolidation and
recall of memory from a previously learnt task in the RAWM, we
report that mTBI experienced after a traumatic event significantly
impairs fear memory to the spatial context but not to the discrete
cue (an auditory tone). Fear/traumatic memory processing in a
spatial context has been attributed primarily as a hippocampal
dependent event (van der Kolk and Fisler, 1995). This hypoth-
esis stipulates that an exposure to a traumatic event interferes
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FIGURE 7 | Global brain-related changes observed at acute
post-mTBI-PTSD time-point. Hallmark potential biomarkers of mTBI (in
humans) were analyzed in brain hemispheres. Western blot analysis showed
a significant increase in axonal marker, neurofilament L (NFL) and
inflammatory marker CD54 (ICAM)-1 levels in mTBI-PTSD groups compared
to control (P = 0.022 and P = 0.016 respectively—A,C). No statistically
significant changes were observed in astrocyte cytoskeletal protein—GFAP
and phospho-tau protein (detected by s202 antibody—CP13) in all groups
analyzed (B,D). Data are presented as mean ± SEM. Arbitrary units were
calculated by normalizing with beta-actin levels [beta-actin blot depicted in
(A), was used to calculate GFAP and ICAM-1 arbitrary values]. Data were
analyzed with Kruskal Wallis-One-Way ANOVA followed by Dunn’s correction
for multiple testing. Asterisk denotes statistical significance as follows:
∗P < 0.05. (N = 4–5).
FIGURE 8 | Doublecortin (DCX) cell counts in the dentate gyrus (DG).
Numbers of DCX+ cells were counted in the subgranular zone (SGZ) of the DG
as depicted in (A). No significant change was observed in the number of DCX+
cells in the subgranular zone (SGZ) of DG. Data are presented as mean ± SEM.
Data were analyzed using Kruskal Wallis-OneWay ANOVA followed by Dunn’s
correction for multiple testing. (N = 4–5). Scale bar represents 95μm.
with the hippocampal based memory processing resulting in the
dissociation and fragmented storage of memory imprinted as
affective and perceptual states that remain unmodified for many
months or years (van der Kolk and Fisler, 1995). We have previ-
ously shown that a single mTBI can alter hippocampal integrity
(notably alteration to glial cells) 10 days post-injury (Mouzon
et al., 2012), and thus possibly the subsequent disruption of
fragmented processing of the traumatic memory response to a
contextual spatial stimulus as shown herein. This indicates that
the combination of a traumatic event and a concussive head
injury can preclude some of the fear or anxiety-related responses
to the contextual environment in which both occurred. The
apparent lack of head injury effect on the Cued fear memory
response is also informative, and perhaps supports the theory that
certain common traits associated with PTSD (such as a precip-
itation of anxiety in response to a powerful environmental cue
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FIGURE 9 | Neuroglial response in the corpus callosum (CC),
hippocampus (CA1), basolateral amygdala (BLA) and hypothalamus
(HypoT), Parietal cortex- Injury site (P-Cortex-IS). (A–D) depicts microglia
IBA+ immunoreactivity in the corpus callosum (CC). There was a
significant increase in mTBI animals compared to controls (P = 0.010); this
was confirmed by quantitative densitometry (optical segmentation) (V).
(E–T) shows astrocyte GFAP+ immunoreactivity in the aforementioned
brain regions. There was a significant increase in astroglial activation in the
CC (E–H), hippocampus (I–L), and P-Cortex-IS of mTBI animals compared
to controls (P = 0.04; P = 0.022, and P = 0.034 respectively—U).
Likewise there was also a significant increase in astroglial activation in the
CC (E–H), and a marginal trend in the hippocampus (I–L) of mTBI-PTSD
animals (P = 0.009; P = 0.09 respectively—U). No significant change was
observed in the P-Cortex-IS of mTBI-PTSD animals compared to controls
(U). Notably PTSD and mTBI-PTSD animals showed an increase in GFAP
(Continued)
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FIGURE 9 | Continued
immunoreactivity in the BLA (M–P) and HypoT by qualitative assessment
(Q–T). This was partly confirmed by densitometric analysis showing a
significant increase in the BLA in mTBI-PTSD animals compared to controls
(P = 0.006), and a marginal trend in PTSD mice compared to controls
(P = 0.071). Data are presented as mean ± SEM. Data were analyzed using
One-Way ANOVA followed by multiple comparisons post-hoc test for each
brain region. A 1 in 10 series of >five average sections were analyzed per
region for each cellular marker per animal. Asterisks denote statistical
significance as follows: ∗P < 0.05; ∗∗P < 0.01. (N = 4–5). Images show
segmented profiles of representative positive immunostaining. Scale bar
represents 95μm.
FIGURE 10 | Distinct periventricular and perivascular astroglia response
to mTBI. GFAP immunostaining revealed a layer of GFAP+ activated cells in
the most superficial layer of the cortex (See white arrows in representative
image—A), beneath the injury site of head injured animals (in both mTBI and
mTBI-PTSD). There was some evidence of multifocal perivascular fibrillary
astrogliosis (B). In some cases these perivascular astroglial cells appeared
hypertrophic with a large cell soma and thick cellular processes (B–D). A
distinct remarkable astrogliosis was observed in the walls of the ventricles
(gray arrows—E) and the neighboring adjacent brain parenchyma (E,F).
Abbreviation; blood vessel (B.V). Scale bar represents 120μm in all images.
associated with the traumatic event) are not mutually exclusive
when it occurs with a mTBI. Fear memory in response to a poten-
tially life threatening stimulus has been suggested to involve the
formation and storage of memory primarily in the amygdala, as
a result of an intense and rapid activation of endogenous plastic-
ity (van der Kolk and Fisler, 1995; Rauch et al., 2006; Diamond
et al., 2007; Shin and Liberzon, 2010). The amygdala is imbedded
deep in the medial temporal lobe structures and, as such, is more
protected from the traumatic head injury inflicted to the top of
the parietal cortex in our model. This implies that the enhanced
processing in the amygdala in response to a traumatic cue is not
significantly influenced by the mTBI or loss of consciousness in
our model and, as such, mTBI does not fully guarantee protection
from trauma-related intrusive memories or PTSD symptoms.
Our data demonstrating the differential effect of mTBI on both
Contextual and discrete Cued fear memory responses are in
agreement with the human study literature showing inconclusive
and sometimes conflicting results on the prevalence of PTSD in
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FIGURE 11 | Distinct white matter pathology and microglia response to
mTBI. There was an apparent reduction in the immunoreactivity of
extracellular matrix protein—Laminin in the corpus callosum (CC) of mTBI
and mTBI-PTSD animals (A–D). Microglia response to injury is shown with
IBA-1 and CD45 antibodies. IBA-1 staining depicted an increase in microglial
activation in white matter/neighboring regions of injured animals (E–J). These
regions included the ventral lateral geniculate nucleus (VLG) in (E), the optic
tract (Op.T) projections surrounding the dorsal lateral geniculate nucleus
(DLG), lateral post-thalamic nuclei (LPTN), and the internal capsule (I.C) in
(F–H) respectively. CD45+ cell (a marker of activated microglia/macrophages)
was also positive in these white matter brain regions (1, J). Notably
ICAM-1/CD54+ cells were also observed in white matter regions of
mTBI-injured animals (both mTBI and combination), they resembled
oligodendroglia-like (and in some cases microglia-like cells—inset K) with a
small round cell body and short sparse processes (see K,L). Scale bar in (L)
represents 95μm in (A–D); 55μm in (E–G); 65μm in (H) and 45μm in (I–L).
some mTBI cases; in particular, this agrees with the observation
that some of these patients only elicit partial (and fewer) intrusive
clusters of PTSD symptoms that do not fully meet the criteria for
the disorder (Ohry et al., 1996;Warden et al., 1997; Gil et al., 2005;
Bryant, 2008). Three other animal models involving a single lat-
eral fluid percussion injury, repetitive (×2) closed head injury and
repetitive (×3) blast over-pressure injury have investigated the
influence of mTBI on fear conditioning (Witgen et al., 2005; Elder
et al., 2012; Klemenhagen et al., 2013). Both repetitive closed head
and blast injuries failed to show any significant effect on contex-
tual fear response, while a single lateral fluid percussion injury
significantly inhibited the Contextual fear memory response seen
in non-injured animals. In the Cued fear memory test, the blast
injury model demonstrated an increase in freezing behavior com-
pared to the un-injured groups, while the closed head injury
model did not reveal any changes in freezing behaviors to the
discrete Cue. Although these findings show differing and conflict-
ing results, it is likely that subtle differences in the experimental
paradigm (such as nature of injury, blast vs. concussion; fre-
quency of injury; single vs. repetitive) and timeline of procedures
(such as time and separation of injury in relation to conditioning
experiments; pre vs. post; days vs. weeks) might have all fac-
tored and contributed to the inconsistent behavioral outcomes.
Furthermore this also highly suggests that mTBI can influence
different aspects associated with presentation of PTSD, and thus
indicates an overlapping neurobiological mechanism that can be
inhibited and/or exacerbated depending on the nature of the TBI.
In addition we observed other distinct behavioral traits in
our model. Animals in the PTSD groups, as expected, exhibited
increased anxiety like behavior, impairment in social behavior
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and hypophagia. mTBI and mTBI-PTSD groups also exhib-
ited some evidence of anxiety-like behavior in the open field
test, but this was also coupled with an increase in disin-
hibitory like behavioral trends in the elevated plus maze and
social novelty recognition test (and this appeared to be osten-
sibly increased in the combination groups). Notably, although
mTBI animals performed normally in social novelty recogni-
tion tests, they exhibited an impaired social interaction, indi-
cating a reduced motivation in these mice to affiliate with
a novel conspecific. Reasons behind these data are unknown,
but further demonstrate the clinical complexity in human TBI
cases and the heterogeneity of the condition (Bogdanova and
Verfaellie, 2012). These data suggest that mTBI is likely related
to a composite of behavioral (disinhibitory) traits typified by
impulsivity, poor risk assessment and indecisiveness and fur-
ther implicate possible diffuse structural damage to the frontal
lobe and/or altered neurotransmitter systems (such as dopamin-
ergic or serotonergic pathways) involved in the control of such
behavioral traits.
SYSTEMIC CHANGES IN mTBI-PTSD MODEL
After observing the different behavioral traits in our model,
we examined some of the physiological changes that might be
responsible for these responses to both trauma and head injury.
We examined plasma levels of corticosterone, and observed a
trend toward an increase in PTSD groups, possibly indicating
an exaggerated adrenal response. Empirical work from the litera-
ture has documented mixed results in relation to neuroendocrine
profiles and hypothalamic-pituitary-adrenal (HPA) axis function
in PTSD patients and animal models, reporting abnormally low
baseline cortisol/corticosterone levels compared to control sub-
jects (Mason et al., 1986; Yehuda et al., 1995a; Goenjian et al.,
1996; Seedat et al., 2003; Rohleder et al., 2004; Zoladz et al.,
2012), while others have reported an elevation in their levels
(Kant et al., 1987; Pitman and Orr, 1990; Maes et al., 1998;
Bremner et al., 2003; Young and Breslau, 2004; Kwon et al., 2011;
see Zoladz and Diamond, 2013 for further extensive review).
Others have also reported an increase in sensitivity and density of
glucocorticoid receptors, adrenal hypertrophy, and an increased
dexamethasone induced suppression of cortisol and adrenocor-
ticotrophine hormone (ACTH), indicating an enhanced negative
feedback (Yehuda et al., 1995b; Goenjian et al., 1996; Stein et al.,
1997; Duval et al., 2004). Reasons behind these heterogeneous
findings in the literature, although unknown, may be uniquely
related to distinct types or nature of traumatic events (acute vs.
chronic, single vs. repeated, psychosocial vs. physical trauma) or
species differences.
Although human studies suggest severity-dependent alter-
ations in HPA axis function post-TBI (Yuan and Wade, 1991;
Cohan et al., 2005; Tanriverdi et al., 2010; Baxter et al., 2013),
in our mouse study mTBI alone did not alter corticosterone levels
compared to controls. Moreover, the combination of stress and
injury also did not abrogate or augment levels of corticosterone,
compared to stress only groups.
In human studies, levels of inflammatory cytokines (IL-6,
TNFα, 1L-1β) have been correlated to the severity of mTBI
consequences and PTSD in some patients (Spivak et al., 1997;
Baker et al., 2001; Gola et al., 2013; Woodcock and Morganti-
Kossmann, 2013). We probed plasma samples for different
cytokines and observed a significant increase in TNFα in stress
only exposed animals, and also a trend toward increase in IL-6
and IL-1β. A inflammatory state typified by alteration in both
humoral (pro/anti-inflammatory cytokines) and cellular factors
(immune cells; CD4+ T cells, and macrophages) from the innate
and adaptive immune system has been suggested to be associated
with depression-anxiety like behaviors in humans and animal
models (Dantzer et al., 2008; Dowlati et al., 2010; Kwon et al.,
2011). The causative factor leading to an increase in low-grade
proinflammatory response to trauma is unknown, but could pos-
sibly be attributed to an exaggerated sympathetic nervous system
activity and the release of adrenal hormones/neurotransmitters
such as norepinephrine, epinephrine, or dopamine that can
both directly and indirectly activate immune cell responses. This
apparent increase in pro-inflammatory cytokines can be detri-
mental to neurobiological systems involved in the regulation of
stress-anxiety behaviors. For example, they can affect neurotrans-
mitter systems by stimulating re-uptake of monoamines from
the synapse through the increase in the activity and density of
transporters of stress-related neurotransmitters: norepinephrine,
dopamine, and 5HT (Zoladz and Diamond, 2013). Further evi-
dence also suggests that proinflammatory cytokines may disrupt
the capacity of stress related glucocorticoid receptors to translo-
cate to the nucleus where they exert their action to suppress the
activity of pro-inflammatory transcription factors such as nuclear
factor kappa B (NF-kB) (Dantzer et al., 2008). Our data therefore
seems to support a classical T-lymphocyte (Th1) proinflamma-
tory cell response in possibly driving the pathogenesis and patho-
physiology of PTSD in our model. In addition to the changes
in proinflammatory cytokines we also observed a trend towards
increase in the levels of anti-inflammatory cytokine 1L-10. A neu-
roprotective role for IL-10 in preventing depression-anxiety like
behavior has been postulated. Rodents with IL-10 over expres-
sion display less anxiety-like behavior, while IL-10 knockouts
display a greater depression-like behavior in a forced swim test
(Mesquita et al., 2008). Moreover, administering 1L-10 attenu-
ated the symptoms associated with a model of sickness behavior,
a syndrome which shares many common features with major
depression, including listlessness, anhedonia, hypophagia, and
social withdrawal (Bluthe et al., 1999). These data are notewor-
thy as they possibly suggest an attempted protective T regulated
cell immunosurveillance mechanism by the body to the trauma
induced physiological changes.
Intriguingly in animals exposed only to mTBI, a significant
increase (×3 fold) in the Th17 cytokine IL-17A was observed
compared to controls, and this effect was abrogated in the com-
bination groups, possibly indicating separate systemic inflamma-
tory response(s) to PTSD and head injury, with mTBI involving a
Th17 classical T lymphocyte inflammatory response at this acute
time point in our model. In interpreting these data it is notewor-
thy to consider that these systemic changes only reflect a snapshot
view at a single time-point post-stress/injury and, as such, it can-
not be excluded that other cytokine profile responses could have
occurred prior to the changes observed 2 weeks post-exposure
and 24 days post-concussion. Nonetheless our data at least seem
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 213 | 18
Ojo et al. Mouse model of PTSD and concussion
to implicate an early robust systemic T-lymphocyte (Th17 cell)
pro-inflammatory response to concussive head injury.
In mice receiving PTSD and mTBI exposures we failed to
observe any distinct trend in cytokine profiles. Although this
result is puzzling it further adds to the complexity of the inter-
action between mTBI and its influence on PTSD related mecha-
nisms, that can make the diagnosis, management and treatment
of both conditions individually or in their combination very chal-
lenging (see Vasterling et al., 2009; Zoladz and Diamond, 2013 for
further discussion).
BRAIN SPECIFIC CHANGES IN THE mTBI-PTSD MODEL
Gross neuropathological changes in a model of mTBI and PTSD
individually or in combination
We assessed brain tissue of animals exposed to stress and con-
cussion for any gross neuropathological outcomes. Our data did
not reveal any gross anatomical changes to brain weight, nor
hippocampal volume, which has been ostensibly associated with
the development and/or predisposition to PTSD in humans and
animal models (Zoladz andDiamond, 2013). In line with our pre-
vious study we also observed a slight reduction in white matter
(corpus callosum) volume in head injured mice (Mouzon et al.,
2012, 2013). The primary hallmark pathological feature of mTBI
is diffuse axonal injury, which occurs in the absence of any gross
anatomical changes that can be visibly imaged with a conven-
tional CT or MRI scan. This damage to the integrity of the white
matter is caused by the initial shearing and tensile forces from
the impact to the head and is well documented in humans (see
seminal work by Rand and Courville, 1946 and review papers
Povlishock, 1993 and Johnson et al., 2013) and thus further sup-
ports the relevance of our concussive head injury model with the
human scenario.
Effects of trauma on acute biomarkers of brain injury
Several biomarkers of mTBI have already been established, these
include proteins that indicate axonal injury, astroglial damage,
BBB dysfunction and neuroinflammation (Dekosky et al., 2013;
Zetterberg et al., 2013). We examined the effects that a back-
ground of repeated stress-trauma may have on selective markers
of early brain injury (GFAP, NFL, ICAM-1, pTau). Initially we
did not expect to see any global changes in these markers from
brain homogenates examined 24 days after injury, due to the
mild nature of the single injury and the time elapsed post-
injury. We were therefore intrigued to discover that there was
a prolonged persistent increase in axonal injury and inflamma-
tory markers—NFL and ICAM-1 respectively in our combination
group. Stress-trauma exposure on its own did not affect the lev-
els of these biomarkers. These results suggests that individuals
exposed to a mTBI in combination with repeated life-threatening
traumatic situations (as regularly encountered by combat sol-
diers) may exhibit a greater magnitude of neurological damage
in the long term due partly to a slower neuro-reparative mecha-
nism, compared to head injured veterans who are not exposed to
repeated traumatic events.
Regional changes in neurogenesis and neuroglial activation
As mentioned above the neurocircuitry models of PTSD impli-
cate frontal and limbic (amygdala and hippocampus) structures
as neurobiological substrates responsible for fear response and
formation of fear associations. A large body of evidence supports
an exaggerated responsivity of the amygdala with the concurrent
dampening of the (inhibitory) prefrontal cortex and hippocampal
activity (vanderKolk andFisler, 1995;Rauchet al., 2006;Diamond
et al., 2007; Vasterling et al., 2009; Shin and Liberzon, 2010).
In mTBI cases, studies have demonstrated a vulnerability of the
hippocampus, frontal white matter, and subcortical structures
with white matter projections to the frontal cortex (Povlishock,
1993). It is currently unclear what direct effects mTBI has on these
frontal and limbic structures in their processing of learned fear
responses and formation of fear associations at the cellular level.
We investigated the effect that mTBI or PTSD either individ-
ually or in combination with each other might have on aspects
of neurogenesis (doublecortin) and neuroglial activation (IBA1,
GFAP) in these aforementioned brain regions.
Although previous animal models have suggested a reduction
in neurogenesis post-trauma (Dranovsky and Hen, 2006) and an
induction in neuronal proliferation post-TBI (Kwon et al., 2011;
Gao and Chen, 2013), our investigation of the immature neuronal
marker doublecortin in the DG, a hippocampal subfield where
postnatal neurogenesis is known to occur, revealed no significant
effect of PTSD, mTBI or their combination. This finding is in
accordance with a most recent study, which investigated the acute
effects of psychosocial stressors in combination with a moderate
controlled cortical impact injury, and reported no effect or inter-
action between PTSD andmTBI onDCX levels in the subgranular
zone (SGZ) (Acosta et al., 2013).
Neuroglial activation features prominently in CNS neuro-
trauma, and is a hallmark feature of our mTBI model (Mouzon
et al., 2013). We investigated microglial (IBA1+) and astroglial
(GFAP+) activation in our models in different brain regions
related to both PTSD and mTBI. We did not observe any sig-
nificant changes in microglial activation in PTSD animals in any
of the brain regions examined. As previously reported there was
a localized increase in microglial activation in the white matter
of mTBI animals (Mouzon et al., 2012, 2013), however, this was
abrogated in the combination groups, suggesting a differential
microglial response to injury in the context of trauma. Whether
these effects are protective or time-dependent in nature remains
to be determined. From our systemic inflammatory cytokine data,
we observed differential responses in the mTBI (increased IL-
17A) and PTSD (increased TNFα) groups. We were unable to
measure regional brain cytokine changes, and thus are uncer-
tain whether these systemic changes might impact on local brain
inflammatory responses. Giving the relative lack of widespread
microglial activation in the brain in general, we consider that the
systemic cytokine responses are of a mild nature or downstream
of other mechanisms, and possibly do not impact on central
inflammatory processes.
Changes to astroglial cells were more pronounced compared to
microglial cells, and were observed in localized regions. An appar-
ent increase in GFAP immunoreactivity was observed in the BLA
and hypothalamus of PTSD and combination groups, and this
was absent in the mTBI only group, indicating a localized PTSD-
dependent astroglial response to trauma in these regions notably
involved in control of stress mechanisms.
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 213 | 19
Ojo et al. Mouse model of PTSD and concussion
Given that we also observed a slightly greater increase in GFAP
levels within the BLA in the combination groups compared to
PTSD alone, indirect influences of the impact of injury in the BLA
cannot be completely excluded.
Specifically our analyses of the hypothalamus consisted of the
combined medial and periventricular zones. These regions con-
tain cytoarchitectonically distinct subnuclei regions such as the
paraventricular, dorsal-medial, ventromedial nuclei, that play a
role in neurohypophysis (release of hormones), regulating neu-
roendocrine and autonomic functions. Although we were unable
to conduct our analyses for each distinct subnuclei separately,
our data still suggest significant widespread changes within these
nuclear groups, and a likely impairment in hypothalamic reg-
ulations of overarching functions that pertain to stress-related
neuroendocrine functions.
The basis of the differences in microglial vs. astroglial
responses in the brain regions we have investigated are unclear,
one possibility is that the response of microglia in these regions
may develop at different rates or endure for different periods and,
as such, could have resolved prior to the timepoint examined
herein.
In addition to the white matter pathologies, we also report a
distinct pathological feature of our mTBI model not previously
documented, typified by a reduction in vascular extracellular
matrix protein (laminin), an increase in ICAM1+ oligoden-
droglia like cells in the white matter, and a localized perivascular
and periventricular activation of microglial and astroglial cells.
The latter reminiscent of CTE like pathology in humans (Omalu
et al., 2011).
CONCLUSION
A major issue in the diagnosis of PTSD and mTBI in their
comorbid form is the clinical heterogeneity and the co-occurrence
of overlapping clinical symptoms such as emotional numbing,
insomnia, fatigue, depression, anxiety, and amnesia. Despite the
numerous epidemiological studies conducted thus far highlight-
ing the cluster of PTSD symptoms in patients exposed to a
mild/moderate head injury, the consequences and the mecha-
nism(s) of interaction between both disorders remain elusive.
This is partly due to the methodological restraints inherent in
human studies, such as the difficulties associated with recruiting
sufficient numbers of unbiased samples, and conducting lon-
gitudinal and prospective study designs. At the outset of this
study we set out to combine our already established concussive
head injury mouse model, which has been extensively character-
ized from 24 h to 24 months post-injury (Mouzon et al., 2012,
2013), with a newly developed model of PTSD. The PTSD model
was specifically tailored to capture the critical aspects of PTSD
symptomatology prevalent in combat veterans, with face and
constructive validity.
We have utilized an ethologically relevant model of unpre-
dictable inescapable predator stress exposure and physical trauma
(footshock) to replicate a debilitating feeling of intense fear, hor-
ror, and helplessness as experienced by PTSD patients (Criterion
A of DSM-5). The face validity of our model was determined
by post-exposure behavioral phenotypes that were analogous to
the human condition as defined by the first four criteria’s of the
DSM-5. (i) PTSD animals showed evidence of intrusive traumatic
memories (criterion B of DSM-5) in the cued and contextual
fear conditioning experiments. (ii) Anxiety and avoidance like
behavior were observed in the elevated plus maze and open
field-tests (Criterion C of DSM-5). (iii) Negative alterations in
social behavior were demonstrated by the impairment in social
interaction and novelty recognition tests (criterion D of DSM-
5). With respect to the constructive validation of our model,
post-stress neurobiological assessment demonstrated evidence
of systemic inflammation and a trend toward neuroendocrine
alterations.
Other aspects of our model that require further investigation
includes: the sustained long-term expression of post-exposure
phenotypes (>1–3 months), the predictive and discriminative
validity of our model, to assess outcomes of novel pharma-
cotherapy, and inherent variability seen in PTSD patients. For
future optimization of our model, because we have focused
on a repeated TMT exposure paradigm we consider it impor-
tant in further development to also include a fear condition-
ing/extinction measure for the repeated TMT stressors. This will
enable assessment of intrusive traumatic memories to the preda-
tor odor when exposed to a reminder cue or a novel context.
Given the importance of psychosocial factors in the development
of PTSD in combat veterans, we also plan to consider includ-
ing a paradigm that will involve social instability to improve our
model (see Zoladz et al., 2008, 2012). To optimize our cogni-
tive paradigm we will also eliminate the pre-training session and
include post-exposure tests with both the RAWM and the Barnes
maze tests.
In addition to the PTSD related phenotypes, we have also
observed that when animals are exposed to both trauma and
mTBI, they exhibit overlapping and distinct neurobehavioral
traits, involving abnormalities in anxiety and social behavior.
This complexity in behavioral phenotypes is also evident in the
systemic and brain specific changes that occur in these ani-
mals, typified by differences in (i) systemic immune response,
(ii) brain inflammatory and (iii) axonal markers of injury, (iv)
astroglial activation and (v) plasticity. These studies have seri-
ous implications when considering the management and diag-
nosis of patients suffering from either PTSD/mTBI or both
(comorbid) conditions. We propose that this model is a use-
ful tool to assess some of these vital interactions between
both psychological and biomechanical trauma and for the iden-
tification of novel biomarkers and therapeutic strategies to
ameliorate the neurological consequences. Our future studies
will focus on characterizing our model in the long-term at
extended time points post-exposure (months to years), and
also involve applying omic technologies to identify the molecu-
lar pathways implicated in the processes underlying co-morbid
mTBI-PTSD.
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